This website will be unavailable from Thursday, May 30, 2024 at 6:00 p.m. through Monday, June 3, 2024 at 7:00 a.m. due to data center maintenance.

 
 
  H.R. No. 1784
 
 
 
R E S O L U T I O N
         WHEREAS, Hemophilia and von Willebrand disease are types of
  bleeding disorders that have been diagnosed in more than 1,100
  Texans; and
         WHEREAS, Hemophilia A, known as factor VIII deficiency, is
  largely an inherited disorder in which one of the proteins needed to
  form blood clots is missing or reduced; in some cases, however,
  there is no family history of the disorder, and the condition is the
  result of a spontaneous gene mutation; approximately one in 5,000
  males born in the United States has hemophilia A; hemophilia B,
  known as factor IX deficiency, is far less common than hemophilia A,
  occurring in only about one in 25,000 male births; and
         WHEREAS, When people with hemophilia are injured, they bleed
  longer than those without hemophilia; small cuts or surface bruises
  are usually not a problem, but more traumatic injuries may result in
  serious problems and potential disability; the main treatment for
  hemophilia involves regular injections or infusions of clotting
  factor derived from donated human blood or from genetically
  engineered products called recombinant clotting factors; and
         WHEREAS, Von Willebrand disease is caused by a defect or
  deficiency of a blood clotting protein and is estimated to occur in
  one to two percent of the population; people with VWD usually bruise
  easily, have recurrent nosebleeds, or bleed after tooth extraction
  or other surgery, but depending on whether the disease is mild or
  severe, there is a variety of treatments available; and
         WHEREAS, Individuals with these diseases often face
  challenges in accessing the appropriate care they need to lead
  healthy and productive lives; they require access to the full range
  of therapies, as well as to proper providers and designated centers
  of excellence suitable to their unique health care needs; moreover,
  they need options for pharmacies and home support services; and
         WHEREAS, In 1973, the National Hemophilia Foundation
  launched a two-year campaign to establish the creation of a
  nationwide network of hemophilia diagnostic and treatment centers,
  and today there are some 140 treatment centers and programs
  throughout the country; access to comprehensive care has been shown
  to markedly improve outcomes for individuals with bleeding
  disorders; and
         WHEREAS, Much work still needs to be done in behalf of people
  with hemophilia and von Willebrand disease, and educating others is
  a vital first step; now, therefore, be it
         RESOLVED, That the House of Representatives of the 81st Texas
  Legislature hereby promote greater public awareness of hemophilia
  and von Willebrand disease and encourage all Texans to become
  better informed of the particular needs of individuals with
  bleeding disorders.
 
  Maldonado
  Villarreal
 
  ______________________________
  Speaker of the House     
 
         I certify that H.R. No. 1784 was adopted by the House on May
  27, 2009, by a non-record vote.
 
  ______________________________
  Chief Clerk of the House